Use of intravenous epoprostenol as a treatment for the digital vasculopathy associated with the scleroderma spectrum of diseases
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Scleroderma and Related Disorders"
DOI: 10.5301/jsrd.5000255
Abstract: Introduction Intravenous prostanoid therapy is recommended for severe systemic sclerosis-related digital vasculopathy. The evidence supporting this recommendation is limited. The aim of this study was to evaluate the safety and efficacy of treating scleroderma spectrum… read more here.
Keywords: spectrum digital; digital vasculopathy; intravenous epoprostenol; epoprostenol infusion ... See more keywords